These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1126 related articles for article (PubMed ID: 27519406)

  • 21. Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the
    Guo Y; Cao X; Yang J; Wu X; Liu Y; Wan B; Hu L; Wang H; Yu F
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33507146
    [No Abstract]   [Full Text] [Related]  

  • 22. Analysis of Xpert MTB/RIF results in retested patients with very low initial bacterial loads: A retrospective study in China.
    Wang J; Zhang X; Huo F; Qin L; Liu R; Shang Y; Yao C; Ma L; Pang Y
    J Infect Public Health; 2023 Jun; 16(6):911-916. PubMed ID: 37068397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The New Xpert MTB/RIF Ultra: Improving Detection of
    Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
    mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rifampicin Resistance and Multidrug-Resistant Tuberculosis Detection Using Xpert MTB/RIF in Wuhan, China: A Retrospective Study.
    Huang H; Zhang Y; Li S; Wang J; Chen J; Pan Z; Gan H
    Microb Drug Resist; 2018 Jun; 24(5):675-679. PubMed ID: 29053085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait.
    Ahmad S; Mokaddas E
    Int J Antimicrob Agents; 2005 Sep; 26(3):205-12. PubMed ID: 16099622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis.
    Zaw MT; Emran NA; Lin Z
    J Infect Public Health; 2018; 11(5):605-610. PubMed ID: 29706316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of rifampicin resistance and 81-bp rifampicin resistant determinant region of rpoB gene mutations of Mycobacterium tuberculosis detected with XpertMTB/Rif in Cross River State, Nigeria.
    Ochang EA; Udoh UA; Emanghe UE; Tiku GO; Offor JB; Odo M; Nkombe E; Owuna OE; Obeten SM; Meremikwu MM
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S145-S146. PubMed ID: 28043515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequencing of the entire rpob gene and characterization of mutations in isolates of Mycobacterium tuberculosis circulating in an endemic tuberculosis setting.
    Luna JF; Montero H; Sampieri CL; Muñiz-Salazar R; Zenteno-Cuevas R
    J Glob Antimicrob Resist; 2019 Dec; 19():98-103. PubMed ID: 30872039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmission of Mycobacterium tuberculosis presenting unusually high discordance between genotypic and phenotypic resistance to rifampicin in an endemic tuberculosis setting.
    Brandao AP; Pinhata JMW; Simonsen V; Oliveira RS; Ghisi KT; Rabello MCS; Fukasava S; Ferrazoli L
    Tuberculosis (Edinb); 2020 Dec; 125():102004. PubMed ID: 33017720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pattern of rpoB gene mutation of Mycobacterium tuberculosis and predictors of rifampicin resistance detected by GeneXpert MTB/RIF assay in Tanzania.
    Torokaa PR; Majigo MV; Kileo H; Urio L; Mbwana MR; Monah MC; Ntibabara SS; Kimambo J; Seleman P; Franklin C; Balama R; Kisonga RM; Joachim A
    PLoS One; 2024; 19(8):e0296563. PubMed ID: 39186753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of the G4 Xpert
    Dharan NJ; Blakemore R; Sloutsky A; Kaur D; Alexander RC; Ghajar M; Musser KA; Escuyer VE; Rowlinson MC; Crowe S; Laniado-Laborin R; Valli E; Nabeta P; Johnson P; Alland D
    BMC Infect Dis; 2016 Dec; 16(1):764. PubMed ID: 27993132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.
    Metcalfe JZ; Makumbirofa S; Makamure B; Sandy C; Bara W; Mason P; Hopewell PC
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):882-9. PubMed ID: 27287639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergy of Xpert (MTB/RIF) and Line probe assay for detection of rifampicin resistant strains of Mycobacterium tuberculosis.
    Hussain S; Sultan S; Riaz S; Hussain H; Javed H; Mazhar R
    J Infect Dev Ctries; 2024 Aug; 18(8):1241-1248. PubMed ID: 39288387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of molecular probes in Xpert MTB/RIF assay in Khyber Pakhtunkhwa, Pakistan.
    Khan AS; Khan MT; Ali S; Khan TA; Qasim M; Malik A; Ali S; Sajjad W; Ain QU; Irfan M
    Arch Microbiol; 2021 Jul; 203(5):2249-2256. PubMed ID: 33640990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
    Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
    Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
    PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
    Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-Life Clinical Practice of Using the Xpert MTB/RIF Assay in Thailand.
    Kawkitinarong K; Suwanpimolkul G; Kateruttanakul P; Manosuthi W; Ubolyam S; Sophonphan J; Avihingsanon A; Ruxrungtham K
    Clin Infect Dis; 2017 May; 64(suppl_2):S171-S178. PubMed ID: 28475796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.